Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Immunology

• Publication date

  2008-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/intimm/dxn037PMID 18448455
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A mechanism for the initiation of allergen-induced T helper type 2 responses

  2008cited by this paper
• IL-27 Suppresses Th2 Cell Development and Th2 Cytokines Production from Polarized Th2 Cells: A Novel Therapeutic Way for Th2-Mediated Allergic Inflammation1

  2007cited by this paper
• IL-1 Receptor Accessory Protein and ST2 Comprise the IL-33 Receptor Complex

  2007cited by this paper
• IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells

  2007cited by this paper
• Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness.

  2006cited by this paper
• Roles of IL-18 in basophils and mast cells.

  2006cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005cited by this paper
• IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell–dependent type 2 innate immunity

  2005cited by this paper
• Viral infections and asthma inception.

  2004cited by this paper
• Interleukin 18 Acts on Memory T Helper Cells Type 1 to Induce Airway Inflammation and Hyperresponsiveness in a Naive Host Mouse

  2004cited by this paper
• Basophils Produce IL-4 and Accumulate in Tissues after Infection with a Th2-inducing Parasite

  2004cited by this paper
• Role of Adaptor TRIF in the MyD88-Independent Toll-Like Receptor Signaling Pathway

  2003cited by this paper
• Regulation of dendritic cell function through toll-like receptors.

  2003cited by this paper
• Toll-like receptors.

  2003cited by this paper
• Nonredundant Roles for CD1d-restricted Natural Killer T Cells and Conventional CD4+ T Cells in the Induction of Immunoglobulin E Antibodies in Response to Interleukin 18 Treatment of Mice

  2003cited by this paper
• Regulation of mast-cell and basophil function and survival by IgE

  2002cited by this paper
• Interleukin-18 regulates both Th1 and Th2 responses.

  2001cited by this paper
• IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6

  2000cited by this paper
• The influence of infections on the development and severity of allergic disorders.

  2000cited by this paper
• Unresponsiveness of MyD88-deficient mice to endotoxin.

  1999cited by this paper
• The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function

  1999cited by this paper
• IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response.

  1999cited by this paper
• IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils.

  1999cited by this paper
• Impaired development of Th2 cells in IL-13-deficient mice.

  1998cited by this paper
• Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling*

  1998cited by this paper
• The IL-1 receptor-related T1 antigen is expressed on immature and mature mast cells and on fetal blood mast cell progenitors.

  1998cited by this paper
• Selective Expression of a Stable Cell Surface Molecule on Type 2 but Not Type 1 Helper T Cells

  1998cited by this paper
• Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function.

  1998cited by this paper
• T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function.

  1998cited by this paper
• IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production.

  1998cited by this paper
• Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells.

  1997cited by this paper
• Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen.

  1997cited by this paper
• CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3

  1994cited by this paper
• Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation.

  1978cited by this paper

• Differential Responsiveness of Human Skin Mast Cells to SCF and IL-33: Reduced Reactivity to SCF but Not to IL-33 in the Post-Mitotic Phase

  2026cites this paper
• Exploring the Potential Role of Interleukin-33 in Inducing Eosinophil-Mediated Fibrosis in Hepatic Alveolar Echinococcosis.

  2026cites this paper
• Disruption of E-cadherin in the airway led to dysplastic stressed cells and asthma-like phenotypes.

  2025cites this paper
• Drug Metabolism and Pharmacokinetics of Oxazolo[4,5-c]quinoline Analogs as Novel Interleukin-33 Inhibitors

  2025cites this paper
• Biological mechanisms and therapeutic prospects of interleukin-33 in pathogenesis and treatment of allergic disease

  2025cites this paper
• Postprandial parasympathetic signals promote lung type 2 immunity.

  2025cites this paper
• The immunoproteasome regulates ILC2 responses by modulating mitochondrial capacity

  2025cites this paper
• Interleukin-33 and soluble ST2 as indicators in patients with asthma

  2025cites this paper
• Anti-ST2 antibody reduces airway hyperresponsiveness mediated by monocyte-derived macrophages during influenza A infection.

  2025cites this paper
• Interleukin‐33 Deficiency Protects the Skin From Ulcer Formation in an Ischemia–Reperfusion‐Induced Decubitus Mouse Model

  2024cites this paper
• Molecular mechanisms and clinical impact of biologic therapies in severe asthma.

  2024cites this paper
• IL-2 family cytokines IL-9 and IL-21 differentially regulate innate and adaptive type 2 immunity in asthma

  2024cites this paper
• Role of IL-33/ST2 Pathway in Inflammatory Bowel Disease: An Overview and Future Perspectives

  2024cites this paper
• UHPLC/MS-based metabolomics of asthmatic mice reveals metabolic changes in group 2 innate lymphoid cells.

  2024cites this paper
• Tff1-expressing Tregs in lung prevent exacerbation of Bleomycin-induced pulmonary fibrosis

  2024cites this paper
• Biologic and Small Molecule Therapy for Treating Moderate to Severe Atopic Dermatitis: Mechanistic Considerations.

  2024cites this paper
• Mast cells control lung type 2 inflammation via prostaglandin E2-driven soluble ST2.

  2024cites this paper
• Mast cells contribute to T‐cell accumulation in the bronchoalveolar space in mice with IL‐33‐induced airway inflammation

  2024cites this paper
• Interleukin-33–activated basophils promote asthma by regulating Th2 cell entry into lung tissue

  2024cites this paper
• From the bench to the clinic: basophils and type 2 epithelial cytokines of thymic stromal lymphopoietin and IL‐33

  2024cites this paper
• ATP functions as a primary alarmin in allergen-induced type 2 immunity.

  2023cites this paper
• Cannabinoid receptor 2 signal promotes type 2 immunity in the lung

  2023cites this paper
• The transcription factor NFIL3/E4BP4 regulates the developmental stage-specific acquisition of basophil function.

  2023cites this paper
• Type-2 CD8+ T-cell formation relies on interleukin-33 and is linked to asthma exacerbations

  2023cites this paper
• The Role of IL-33/ST2 in COPD and Its Future as an Antibody Therapy

  2023cites this paper
• A Deep View of the Biological Property of Interleukin-33 and Its Dysfunction in the Gut

  2023cites this paper
• Airway Epithelium: A Neglected but Crucial Cell Type in Asthma Pathobiology

  2023cites this paper
• Engineering the IL‐4/IL‐13 axis for targeted immune modulation

  2023cites this paper
• C5aR1 activation in mice controls inflammatory eosinophil recruitment and functions in allergic asthma

  2023cites this paper
• Enhanced mucosal response in sheep harbouring βA beta‐globin against haemonchosis

  2023cites this paper
• Epithelial-intrinsic defects in TGFβR signaling drive local allergic inflammation manifesting as eosinophilic esophagitis

  2023cites this paper
• ILC2s in skin disorders.

  2023cites this paper
• Interleukin‐33 increases type 2 innate lymphoid cell count and their activation in eosinophilic asthma

  2023cites this paper
• Mechanism of action of certain medicinal plants for the treatment of asthma.

  2023cites this paper
• Pruritus: A Sensory Symptom Generated in Cutaneous Immuno-Neuronal Crosstalk

  2022cites this paper
• Signaling and functions of interleukin-33 in immune regulation and diseases

  2022cites this paper
• Temporal Quantitative Phosphoproteomics Profiling of Interleukin-33 Signaling Network Reveals Unique Modulators of Monocyte Activation

  2022cites this paper
• Emerging Functions of IL-33 in Homeostasis and Immunity.

  2022cites this paper
• Interleukin-3 Potentiates Murine Basophils for Protease Allergen-Induced Interleukin-4 Production

  2022cites this paper
• Inhibiting the P2Y13 receptor reduces IL-33 and HMGB1 lung concentrations and inflammatory cell infiltration in a murine model of asthma

  2022cites this paper
• “Just one word, plastic!”: Controversies and caveats in innate lymphoid cell plasticity

  2022cites this paper
• Immunotherapy in the Treatment of Allergic Rhinitis in Children

  2022cites this paper
• Betuletol, a Propolis Component, Suppresses IL-33 Gene Expression and Effective against Eosinophilia

  2022cites this paper
• Emerging roles for IL-25 and IL-33 in colorectal cancer tumorigenesis

  2022cites this paper
• Interleukin-3 Potentiates Murine Basophils for Protease Allergen-Induced Interleukin-4 Production

  2022cites this paper
• Comorbid allergic rhinitis and asthma: important clinical considerations

  2022cites this paper
• IL-33-induced keratoconjunctivitis is mediated by group 2 innate lymphoid cells in mice.

  2022cites this paper
• How Do Pollen Allergens Sensitize?

  2022cites this paper
• Neuro-immune communication regulating pruritus in atopic dermatitis.

  2022cites this paper
• Increased expression of IL1-RL1 is associated with type 2 and type 1 immune pathways in asthma

  2022cites this paper
• Mesenchymal Progenitors set the homeostatic inflammatory milieu via the TAK1-NFkB axis

  2022cites this paper
• Regulatory T Cells, a Viable Target Against Airway Allergic Inflammatory Responses in Asthma

  2022cites this paper
• Role of interleukin 5-induced eosinophils in interleukin 33-triggered airway inflammation in mice.

  2021cites this paper
• LKB1 deficiency upregulates RELM-α to drive airway goblet cell metaplasia

  2021cites this paper
• TLR4 Deficiency Exacerbates Biliary Injuries and Peribiliary Fibrosis Caused by Clonorchis sinensis in a Resistant Mouse Strain

  2021cites this paper
• IL-33 priming amplifies ATP-mediated mast cell cytokine production.

  2021cites this paper
• Autophagy of mucin granules contributes to resolution of airway mucous metaplasia

  2021cites this paper
• The role of the immune response in the etiopathogenesis of endometriosis

  2021cites this paper
• The Janus Face of IL-33 Signaling in Tumor Development and Immune Escape

  2021cites this paper
• Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33

  2021cites this paper
• Interleukin-13 as a target to alleviate severe coronavirus disease 2019 and restore lung homeostasis

  2021cites this paper
• Effects of cytokine signaling inhibition on inflammation-driven tissue remodeling

  2021cites this paper
• Role of Innate Immune System in Environmental Lung Diseases

  2021cites this paper
• 12/15-Lipoxygenase Regulates IL-33-Induced Eosinophilic Airway Inflammation in Mice

  2021cites this paper
• c-Rel Is Required for IL-33-Dependent Activation of ILC2s

  2021cites this paper
• Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity

  2021cites this paper
• The role of interleukin-33 in the pathogenesis, and treatment of severe asthma

  2021cites this paper
• The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention.

  2021cites this paper
• Association study between asthma and single nucleotide polymorphisms of ORMDL3, GSDMB, and IL1RL1 genes in an Algerian population

  2021cites this paper
• Interleukin‐33 improves local immunity during Gram‐negative pneumonia by a combined effect on neutrophils and inflammatory monocytes

  2020cites this paper
• Egg yolk augments type 2 immunity by activating innate cells

  2020cites this paper
• Apoptotic and inflammatory signalling pathways in dendritic cells

  2020cites this paper
• Allergic inflammation is initiated by IL-33–dependent crosstalk between mast cells and basophils

  2020cites this paper
• Loss of IL-33 enhances elastase-induced and cigarette smoke extract-induced emphysema in mice

  2020cites this paper
• Does interleukin‐33 level correlate with the activity of Pemphigus vulgaris?: A case‐control study

  2020cites this paper
• Upregulation of miR-155 regulates group 2 innate lymphoid cells by targeting c-maf in allergic rhinitis.

  2020cites this paper
• The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators

  2020cites this paper
• Basophils and Eosinophils in Nematode Infections

  2020cites this paper
• Characterization of immune responses and the lung transcriptome in a murine model of IL-33 challenge.

  2020cites this paper
• The Innate Lymphoid System Is a Critical Player in the Manifestation of Mucoinflammatory Airway Disease in Mice

  2020cites this paper
• Research Progress in Atopic March

  2020cites this paper
• Lung fibroblasts produce interleukin-33 in response to stimulation by retinoblastoma-binding protein 9 via production of prostaglandin E2.

  2020cites this paper
• IL-33 and its decoy sST2 in patients with Alzheimer’s disease and mild cognitive impairment

  2020cites this paper
• Group 2 Innate Lymphoid Cells and the House Dust Mite-Induced Asthma Mouse Model

  2020cites this paper
• Secreted Phospholipase A2 Group X Acts as an Adjuvant for Type 2 Inflammation, Leading to an Allergen-Specific Immune Response in the Lung

  2020cites this paper
• Evaluation of Human MSCs Treatment Frequency on Airway Inflammation in a Mouse Model of Acute Asthma

  2020cites this paper
• Regnase-1 degradation is crucial for interleukin-33- and interleukin-25-mediated ILC2 activation.

  2020cites this paper
• ncRNAs in Type-2 Immunity

  2020cites this paper
• The IL-33/ST2 Axis in Immune Responses Against Parasitic Disease: Potential Therapeutic Applications

  2020cites this paper
• Association of Single-Nucleotide Polymorphisms With Chronic Rhinosinusitis in a Southwestern Han Chinese Population: A Replication Study

  2019cites this paper
• Extrinsic and Intrinsic Immunometabolism Converge: Perspectives on Future Research and Therapeutic Development for Obesity

  2019cites this paper
• Longitudinal single cell profiling of regulatory T cells identifies IL-33 as a driver of tumor immunosuppression

  2019cites this paper
• Transcription factor and cytokine regulation of eosinophil lineage commitment.

  2019cites this paper
• Innate Immune Responses Associated with Resistance against Haemonchus contortus in Morada Nova Sheep

  2019cites this paper
• The role of toll‐like receptor 4 and mast cell in the ameliorating effect of electroacupuncture on visceral hypersensitivity in rats

  2019cites this paper
• Interleukin-18 in Health and Disease

  2019influential citation
• 2019IL-33 and its decoy sST2 in patients with Alzheimer’s Disease and Mild Cognitive Impairment

  2019cites this paper
• IL33: Roles in Allergic Inflammation and Therapeutic Perspectives

  2019cites this paper
• IL-33 blockade impacts mediators of persistence and exacerbation in a model of chronic airway inflammation.

  2019cites this paper
• The interleukin-33 receptor contributes to pulmonary responses to ozone in male mice: role of the microbiome

  2019cites this paper